PINL:GRPOF - Post by User
Post by
Herb255on Jun 11, 2019 2:17pm
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
210 Views
Post# 29815999
Panag Pharma Completes Phase 3 Trial With Awaye™
Panag Pharma Completes Phase 3 Trial With Awaye™Recently acquired by Tetra Bio-Pharma, Panag Pharma’s terpene-derived topical product is aimed at pain caused by osteoarthritis of the knee
Synopsis: Phase 3 of Awaye complete. Followup with patients scheduled for third week of June. Results should be released sometime July-ish. Article states they are aiming to begin sales by Q4 2019.
https://web.tmxmoney.com/article.php?newsid=7680561606726032&qm_symbol=TBP